Jiangsu Carephar Pharmaceutical Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 2006-06-08
- Employees
- -
- Market Cap
- -
- Website
- http://www.carephar.com
Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)A Study of Single and Multiple Ascending Doses of H021 in Healthy Participants
- First Posted Date
- 2024-10-04
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- Jiangsu Carephar Pharmaceutical Co., Ltd.
- Target Recruit Count
- 64
- Registration Number
- NCT06627556
- Locations
- 🇦🇺
Nucleus Network Ply Ltd., Melbourne, Victoria, Australia
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of Oral Doses of H008
Phase 1
Completed
- Conditions
- Erosive Esophagitis
- Interventions
- First Posted Date
- 2021-09-20
- Last Posted Date
- 2023-12-15
- Lead Sponsor
- Jiangsu Carephar Pharmaceutical Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT05050188
- Locations
- 🇺🇸
Syneos Health, Miami, Florida, United States
News
No news found